FDMT holder plans sale of 26,842 Class A shares

Accepted by SEC EDGAR 08/04/2026 - 06:08 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

The issuer of FDMT Class A Common Stock has a planned sale of up to 26,842 shares, to be executed through Goldman Sachs & Co. LLC on the NASD on or about August 4, 2026, with an aggregate market value of $275,398.92. The shares were acquired from the issuer in a private transaction on December 15, 2020.

Over the prior three months, shareholder David Kirn reported multiple sales of Class A Common Stock, including 114,746 shares for $1,200,851.31 on June 22, 2026, 42,608 shares for $548,177.48 on July 9, 2026, and several smaller transactions on June 1, July 10, and August 3, 2026.

Key Figures

Proposed shares to be sold: 26,842 shares Aggregate market value of proposed sale: $275,398.92 Shares sold June 22, 2026: 114,746 shares +3 more

6 metrics

Proposed shares to be sold 26,842 shares Planned sale of Class A Common Stock on or about August 4, 2026

Aggregate market value of proposed sale $275,398.92 Estimated value of 26,842 Class A shares to be sold

Shares sold June 22, 2026 114,746 shares Class A Common Stock sold by David Kirn on June 22, 2026

Proceeds June 22, 2026 sale $1,200,851.31 Aggregate sale price for 114,746 shares on June 22, 2026

Shares sold July 9, 2026 42,608 shares Class A Common Stock sold by David Kirn on July 9, 2026

Proceeds July 9, 2026 sale $548,177.48 Aggregate sale price for 42,608 shares on July 9, 2026

Key Terms

Form 144, aggregate market value, private transaction, Class A Common

4 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

aggregate market value financial

"Class A Common | Goldman Sachs & Co. LLC... | 275398.92"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

private transaction financial

"Acquired from issuer in private transaction"

A private transaction is the sale or transfer of securities, assets, or ownership stakes carried out directly between a small number of parties rather than on a public exchange. For investors it matters because these deals are less visible and often less liquid than public trades, so pricing can be harder to verify, the investment can be harder to sell quickly, and buyers or sellers may gain strategic advantages not available in open markets — like negotiated terms similar to a private garage sale versus a crowded marketplace.

Class A Common financial

"Class A Common | Goldman Sachs & Co. LLC..."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does FDMT's Form 144 filing disclose about upcoming stock sales?

The filing shows a planned sale of 26,842 Class A shares of FDMT through Goldman Sachs & Co. LLC on or about August 4, 2026, with an estimated aggregate market value of $275,398.92.

How many FDMT shares are proposed to be sold under this notice?

The notice covers a proposed sale of up to 26,842 Class A Common shares. These shares were acquired from the issuer in a private transaction on December 15, 2020 and are planned to be sold on the NASD market.

Who is the broker for the planned FDMT share sale in this Form 144?

The planned sale of 26,842 FDMT Class A shares will be handled by Goldman Sachs & Co. LLC, located at 200 West Street, New York, NY 10282, with trading expected on the NASD market.

What recent FDMT stock sales by David Kirn are disclosed?

The filing lists several sales of FDMT Class A shares by David Kirn, including 114,746 shares for $1,200,851.31 on June 22, 2026 and 42,608 shares for $548,177.48 on July 9, 2026, plus smaller trades on other dates.

When were the FDMT shares being sold under this Form 144 originally acquired?

The 26,842 FDMT Class A shares covered by the planned sale were acquired from the issuer in a private transaction on December 15, 2020, according to the disclosure.

What is the total dollar value of the largest recent FDMT share sale by David Kirn?

The largest individual recent sale disclosed is 114,746 FDMT Class A shares sold for an aggregate of $1,200,851.31 on June 22, 2026, as part of the past three months’ transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001834021
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	4D Molecular Therapeutics, Inc.
SEC File Number	001-39782
Address of Issuer	5858 Horton Street Suite 455 Emeryville CALIFORNIA 94608
Phone	1-510-505-2680
Name of Person for Whose Account the Securities are To Be Sold	David Kirn
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	26842	275398.92	52276254	08/04/2026	NASD

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	12/15/2020	Acquired from issuer in private transaction	Issuer			26842	12/15/2020	None

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608	Class A Common	08/03/2026	12415	124722.33
David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608	Class A Common	06/01/2026	1922	19257.86
David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608	Class A Common	06/22/2026	114746	1200851.31
David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608	Class A Common	07/09/2026	42608	548177.48
David Kirn 5858 Horton Street Suite 455 Emeryville CA 94608	Class A Common	07/10/2026	15725	189233.08

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 01/09/2026 that is intended to comply with Rule 10b5-1(c).
Date of Notice	08/04/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	01/09/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of David Kirn
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)